The ß2-adrenergic receptor antagonist ICI-118,551 blocks the constitutively activated HIF signalling in hemangioblastomas from von Hippel-Lindau disease.
Sci Rep
; 9(1): 10062, 2019 07 11.
Article
in En
| MEDLINE
| ID: mdl-31296894
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Propanolamines
/
Cell Nucleus
/
Central Nervous System Neoplasms
/
Hemangioblastoma
/
Adrenergic beta-Antagonists
/
Hypoxia-Inducible Factor 1, alpha Subunit
/
Von Hippel-Lindau Disease
Limits:
Humans
Language:
En
Journal:
Sci Rep
Year:
2019
Document type:
Article
Affiliation country:
Country of publication: